These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 29265579)

  • 1. Successful treatment with rituximab in a Japanese patient with systemic sclerosis-associated interstitial lung disease resistant to oral steroid and cyclophosphamide.
    Numajiri H; Yoshizaki A; Ebata S; Fukasawa T; Yamashita T; Takahashi T; Taniguchi T; Asano Y; Sato S
    J Dermatol; 2018 Jun; 45(6):e140-e141. PubMed ID: 29265579
    [No Abstract]   [Full Text] [Related]  

  • 2. Unprecedented success of rituximab therapy for prednisolone- and immunosuppressant-resistant systemic sclerosis-associated interstitial lung disease.
    Ebata S; Yoshizaki A; Fukasawa T; Nakamura K; Yamashita T; Miura S; Saigusa R; Ichimura Y; Takahashi T; Hirabayashi M; Taniguchi T; Akamata K; Asano Y; Sato S
    Scand J Rheumatol; 2017 May; 46(3):247-252. PubMed ID: 27900875
    [No Abstract]   [Full Text] [Related]  

  • 3. Rituximab therapy is more effective than cyclophosphamide therapy for Japanese patients with anti-topoisomerase I-positive systemic sclerosis-associated interstitial lung disease.
    Ebata S; Yoshizaki A; Fukasawa T; Miura S; Takahashi T; Sumida H; Asano Y; Sato S
    J Dermatol; 2019 Nov; 46(11):1006-1013. PubMed ID: 31502326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unusual association of systemic sclerosis and ankylosing spondylitis.
    Soledade CS; Sampaio-Barros PD; Samara AM; Marques-Neto JF
    Clin Rheumatol; 2005 Nov; 24(6):652-4. PubMed ID: 15338450
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum LL-37 levels correlate with the efficacy of i.v. cyclophosphamide pulse for skin sclerosis and interstitial lung disease in systemic sclerosis.
    Takahashi T; Asano Y; Taniguchi T; Yoshizaki A; Sato S
    J Dermatol; 2017 Apr; 44(4):468-469. PubMed ID: 28378437
    [No Abstract]   [Full Text] [Related]  

  • 6. A new therapy for systemic sclerosis-associated interstitial lung disease.
    Kondoh Y
    Respir Investig; 2020 Jul; 58(4):227-229. PubMed ID: 32451295
    [No Abstract]   [Full Text] [Related]  

  • 7. Rituximab in the treatment of systemic sclerosis-associated interstitial lung disease: comment on the article by Yoo.
    Daoussis D; Andonopoulos AP
    Rheumatol Int; 2011 Jun; 31(6):841-2. PubMed ID: 20376665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclophosphamide-refractory scleroderma-associated interstitial lung disease: remarkable clinical and radiological response to a single course of rituximab combined with high-dose corticosteroids.
    Haroon M; McLaughlin P; Henry M; Harney S
    Ther Adv Respir Dis; 2011 Oct; 5(5):299-304. PubMed ID: 21593063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment Algorithms for Systemic Sclerosis According to Experts.
    Fernández-Codina A; Walker KM; Pope JE;
    Arthritis Rheumatol; 2018 Nov; 70(11):1820-1828. PubMed ID: 29781586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment of steroid and cyclophosphamide-resistant diffuse scleroderma-associated interstitial lung disease with rituximab.
    Yoo WH
    Rheumatol Int; 2012 Mar; 32(3):795-8. PubMed ID: 20058013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of long-term treatment with rituximab on pulmonary function and skin fibrosis in patients with diffuse systemic sclerosis.
    Daoussis D; Liossis SN; Tsamandas AC; Kalogeropoulou C; Paliogianni F; Sirinian C; Yiannopoulos G; Andonopoulos AP
    Clin Exp Rheumatol; 2012; 30(2 Suppl 71):S17-22. PubMed ID: 22244622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scleroderma lung: pathogenesis, evaluation, and current therapy.
    Co HT; Block JA; Sequeira W
    Am J Ther; 2000 Sep; 7(5):321-4. PubMed ID: 11317180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rituximab Experience in Patients With Long-standing Systemic Sclerosis-Associated Interstitial Lung Disease: A Series of 14 Patients.
    Sari A; Guven D; Armagan B; Erden A; Kalyoncu U; Karadag O; Apras Bilgen S; Ertenli I; Kiraz S; Akdogan A
    J Clin Rheumatol; 2017 Dec; 23(8):411-415. PubMed ID: 28926468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rituximab in the treatment of systemic sclerosis-related interstitial lung disease: a systematic review and meta-analysis.
    Goswami RP; Ray A; Chatterjee M; Mukherjee A; Sircar G; Ghosh P
    Rheumatology (Oxford); 2021 Feb; 60(2):557-567. PubMed ID: 33164098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Centrilobular fibrosis: an underrecognized pattern in systemic sclerosis.
    de Souza RB; Borges CT; Capelozzi VL; Parra ER; Jatene FB; Kavakama J; Kairalla RA; Bonfá E
    Respiration; 2009; 77(4):389-97. PubMed ID: 18799868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclophosphamide in scleroderma lung disease.
    Kuschner WG
    N Engl J Med; 2006 Sep; 355(11):1173; author reply 1174. PubMed ID: 16971726
    [No Abstract]   [Full Text] [Related]  

  • 17. High-dose prednisolone and bolus cyclophosphamide in interstitial lung disease associated with systemic sclerosis: a prospective open study.
    Wanchu A; Suryanaryana BS; Sharma S; Sharma A; Bambery P
    Int J Rheum Dis; 2009 Sep; 12(3):239-42. PubMed ID: 20374353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is there a role for B-cell depletion as therapy for scleroderma? A case report and review of the literature.
    Daoussis D; Liossis SN; Tsamandas AC; Kalogeropoulou C; Kazantzi A; Korfiatis P; Yiannopoulos G; Andonopoulos AP
    Semin Arthritis Rheum; 2010 Oct; 40(2):127-36. PubMed ID: 20004954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does high-dose extended course cyclophosphamide and methylprednisolone pulse therapy have a role in the management of systemic sclerosis-related interstitial lung disease?
    Abignano G; Bissell LA; Emery P; Del Galdo F; Buch MH
    Rheumatology (Oxford); 2016 Dec; 55(12):2273-2275. PubMed ID: 27744357
    [No Abstract]   [Full Text] [Related]  

  • 20. Dermatomyositis with Rapidly Progressive Interstitial Lung Disease Treated with Rituximab: A Report of 3 Cases in Japan.
    Tokunaga K; Hagino N
    Intern Med; 2017; 56(11):1399-1403. PubMed ID: 28566605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.